• Astellas buys Potenza Therapeutics for up to $405m pharmaceutical-technology
    December 18, 2018
    Japanese pharmaceutical company Astellas Pharma has acquired US-based Potenza Therapeutics for a total consideration of up to $405m.
  • Astellas Acquires Potenza Therapeutics pharmafocusasia
    December 17, 2018
PharmaSources Customer Service